000 01371 a2200373 4500
005 20250511200836.0
264 0 _c19900214
008 199002s 0 0 eng d
022 _a0002-8703
024 7 _a10.1016/s0002-8703(05)80073-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPratt, C M
245 0 0 _aEfficacy and safety of moricizine in patients with congestive heart failure: a summary of the experience in the United States.
_h[electronic resource]
260 _bAmerican heart journal
_cJan 1990
300 _a1-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Arrhythmia Agents
_xtherapeutic use
650 0 4 _aArrhythmias, Cardiac
_xchemically induced
650 0 4 _aCardiac Complexes, Premature
_xprevention & control
650 0 4 _aDeath, Sudden
_xetiology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHeart Failure
_xcomplications
650 0 4 _aHumans
650 0 4 _aMoricizine
650 0 4 _aPhenothiazines
_xadverse effects
650 0 4 _aRecurrence
650 0 4 _aStroke Volume
700 1 _aPodrid, P
700 1 _aGreatrix, B
700 1 _aBorland, R M
700 1 _aMahler, S
773 0 _tAmerican heart journal
_gvol. 119
_gno. 1
_gp. 1-7
856 4 0 _uhttps://doi.org/10.1016/s0002-8703(05)80073-0
_zAvailable from publisher's website
999 _c1695081
_d1695081